Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

Biotech

A different approach to MDD I’m big on companies having a unique approach to whatever they are doing. Many psychedelics companies are targetting depression but from a psychedelic-assisted therapy…
Mind Medicine (MMED.NE) announced the publication of the first pharmacogenetic data on LSD to help personalize dosing. The study results from a pooled secondary analysis of four Phase I…
Cybin (CYBN.NE) announced they have filed an international patent application that brings the potential to obtain patent coverage in 153 countries. The application is governed by the Patent Cooperation…
‘Growth hacking’ Early on in the shroom boom critics had one major pain point – legalization is too far away. I remember the stiffs at the Cannacord conference a…
Sixth Wave Innovations (SIXW.C) inked an agreement with the Alberta Center for Advanced Micro/Nanotechnology Products (ACAMP) to create a hybrid prototype technology that combines radio frequency (RF) based technology…
Mydecine Innovations Group (MYCO.C) announced that they have received approval from Health Canada to significantly expand their cultivation capacity at their Canadian Current Good Manufacturing Practice (cGMP) facility at…
Cybin (CYBN.E) filed a new provisional patent application for its ongoing drug candidate programs today, according to a press release. The application includes compositions which the company anticipates will…
Multiple pivots Mind Cure (MCUR.C) began as a mushroom nootropic deal that has since shifted to ibogaine production and the development digital platforms. The company has been able to…
In a groundbreaking story MindMed (MNMD.Q) announced today has been granted approval by the Swiss Ethics Committee to evaluate the acute effects of different doses of mescaline and the…
XPhyto Therapeutics (XPHY.C) announced their partner Max Pharma GmbH will begin to sell XPhyto’s rapid point-of-care Covid-19 PCR test system (Covid-ID Lab) in Germany next week. The Covid-ID Lab…